CRAIG K. SVENSSON; THOMAS J. CALI, PHARM. D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: We read with interest the report by Pederson and associates (1) on the use of oral activated charcoal in dialysis patients with generalized pruritus. Although they concluded that ". . . oral activated charcoal is an economical, safe, and effective treatment . . .," they fail to address one very important issue in their report, namely, what effect the administration of charcoal would have on concurrent drug therapy. Because many patients on dialysis have multiorgan disease, multiple drug therapy is common. In reviewing the medication regimens of four patients in the Dialysis Unit at the University of
SVENSSON CK, CALI TJ. Drug Adsorption by Charcoal. Ann Intern Med. 1981;94:281. doi: https://doi.org/10.7326/0003-4819-94-2-281_1
Download citation file:
Published: Ann Intern Med. 1981;94(2):281.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use